Cedric is CEO and member of the Board of Directors of Confo Therapeutics since October 2016. During his tenure, Confo has raised €30 million in financing, signed 3 pharma partnerships and evolved from an early stage platform company to a clinical-stage drug development company.
He previously served as Vice President of Business Development at Ablynx and played a key role in landmark deals. Prior to moving to business development, Cedric worked through various R&D functions at Ablynx, first as a scientist in the pharmacology group and later as project manager, leading cross-functional project teams from discovery up to Phase 2 clinical studies. Cedric has a PhD in bioscience engineering from KU Leuven (Belgium).